FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Guide on 510(k) Transfers/Sales

FDA publishes a draft guidance entitled Transfer of a Premarket Notification (510(k)) Clearance Questions and Answers.

latest-news-card-1
Medical Devices

Pandemic Diagnostic Testing Plan Needed: GAO

The Government Accountability Office says there are things HHS, FDA, and other units should do to help create a coordinated national approach for diag...

latest-news-card-1
Human Drugs

2 FDA Officials Part of Wrongful Termination Lawsuit

Two former FDA officials add their names to a class-action wrongful termination lawsuit alleging the federal government knowingly used flawed and inac...

latest-news-card-1
FDA General

Sources Question FDA Internal AI: NBC

Anonymous and named sources raise questions for NBC News about FDAs use of internal AI tools in product reviews and approvals.

latest-news-card-1
Human Drugs

Makary Pledges Mifepristone Study

FDA commissioner Martin Makary says agency scientists will review the safety of the abortion drug mifepristone based on findings from a study conducte...

latest-news-card-1
Biologics

Makary Struggles to Clarify New Covid Recommendations

FDA commissioner Marty Makary appears to struggle to convey the governments Covid-19 vaccine recommendations in a contentious interview on CBSs Face t...

latest-news-card-1
Human Drugs

Rechon Life Sciences Violations

FDA warns Swedens Rechon Life Sciences about CGMP violations in its production of finished drugs.

latest-news-card-1
Human Drugs

CGMP Violations at Zhejiang Easyclean

FDA warns Chinas Zhejiang Easyclean Daily Chemical Co. about CGMP violations in its production of finished drugs.

Medical Devices

FDA Drops LDT Regulation, Looks to RUOs: Attorneys

Two Hyman, Phelps & McNamara attorneys say FDA may give research-use-only products greater regulatory scrutiny as a way to maintain some level of cont...

latest-news-card-1
Biologics

CBERs Prasad Outlines Rare Disease Goals

CBER director Vinay Prasad outlines his expectations for advancing rare disease products, such as embracing both surrogate endpoints for accelerated a...